Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanne Mortimer

Showing results (51-60 of 110) with videos related to

Pageof 11
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2013
Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistanceSaul J Priceman, Maciej Kujawski, Shudan Shen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 22, 2013
Barriers to treatment in patients with locally advanced breast cancerLaura Bourdeanu, Thehang Luu, Norma Baker, et al.
Oncotarget|October 6, 2017
Correction: Genomic mutation-driven metastatic breast cancer therapy: a single center experienceYuan Yuan, Susan E Yost, John Yim, et al.
Oncotarget|January 7, 2017
Genomic mutation-driven metastatic breast cancer therapy: a single center experienceYuan Yuan, Susan E Yost, John Yim, et al.
Plos One|November 18, 2014
A phase 1 study of 131I-CLR1404 in patients with relapsed or refractory advanced solid tumors: dosimetry, biodistribution, pharmacokinetics, and safetyJoseph J Grudzinski, Benjamin Titz, Kevin Kozak, et al.
Cancers|June 10, 2022
Molecular Assessment of HER2 to Identify Signatures Associated with Therapy Response in HER2-Positive Breast CancerAdam L Maddox, Matthew S Brehove, Kiarash R Eliato, et al.
Clinical Breast Cancer|December 3, 2013
The effect of aromatase inhibition on the cognitive function of older patients with breast cancerArti Hurria, Sunita K Patel, Joanne Mortimer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661Gini F Fleming, Neal J Meropol, Gary L Rosner, et al.
Plos One|March 10, 2020
Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosisTing-Fang He, Susan E Yost, Paul H Frankel, et al.
Nature Communications|October 18, 2018
Human breast tumor-infiltrating CD8<sup>+</sup> T cells retain polyfunctionality despite PD-1 expressionColt A Egelston, Christian Avalos, Travis Y Tu, et al.
Pageof 11

Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2013
Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistanceSaul J Priceman, Maciej Kujawski, Shudan Shen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 22, 2013
Barriers to treatment in patients with locally advanced breast cancerLaura Bourdeanu, Thehang Luu, Norma Baker, et al.
Oncotarget|October 6, 2017
Correction: Genomic mutation-driven metastatic breast cancer therapy: a single center experienceYuan Yuan, Susan E Yost, John Yim, et al.
Oncotarget|January 7, 2017
Genomic mutation-driven metastatic breast cancer therapy: a single center experienceYuan Yuan, Susan E Yost, John Yim, et al.
Plos One|November 18, 2014
A phase 1 study of 131I-CLR1404 in patients with relapsed or refractory advanced solid tumors: dosimetry, biodistribution, pharmacokinetics, and safetyJoseph J Grudzinski, Benjamin Titz, Kevin Kozak, et al.
Cancers|June 10, 2022
Molecular Assessment of HER2 to Identify Signatures Associated with Therapy Response in HER2-Positive Breast CancerAdam L Maddox, Matthew S Brehove, Kiarash R Eliato, et al.
Clinical Breast Cancer|December 3, 2013
The effect of aromatase inhibition on the cognitive function of older patients with breast cancerArti Hurria, Sunita K Patel, Joanne Mortimer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661Gini F Fleming, Neal J Meropol, Gary L Rosner, et al.
Plos One|March 10, 2020
Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosisTing-Fang He, Susan E Yost, Paul H Frankel, et al.
Nature Communications|October 18, 2018
Human breast tumor-infiltrating CD8<sup>+</sup> T cells retain polyfunctionality despite PD-1 expressionColt A Egelston, Christian Avalos, Travis Y Tu, et al.
Pageof 11